ITEM VIEW

Variation in HIV prevalence and the population-level effects of antiretroviral therapy in reducing tuberculosis incidence in South Africa

dc.contributor.authorSloot, R.en_ZA
dc.contributor.authorMaarman, G. J.en_ZA
dc.contributor.authorOsman, M.en_ZA
dc.contributor.authorMarx, F. M.en_ZA
dc.date.accessioned2019-11-22T06:53:28Z
dc.date.available2019-11-22T06:53:28Z
dc.date.issued2018
dc.identifier.citationSloot, R. et al. 2018. Variation in HIV prevalence and the population-level effects of antiretroviral therapy in reducing tuberculosis incidence in South Africa. South African Medical Journal, 108(8):606, doi:10.7196/SAMJ.2018.v108i8.13394.
dc.identifier.issn2078-5135 (online)
dc.identifier.issn0256-9574 (print)
dc.identifier.otherdoi:10.7196/SAMJ.2018.v108i8.13394
dc.identifier.urihttp://hdl.handle.net/10019.1/106867
dc.descriptionCITATION: Sloot, R. et al. 2018. Variation in HIV prevalence and the population-level effects of antiretroviral therapy in reducing tuberculosis incidence in South Africa. South African Medical Journal, 108(8):606, doi:10.7196/SAMJ.2018.v108i8.13394.
dc.descriptionThe original publication is available at http://www.samj.org.za
dc.description.abstractThe current year (2018) marks the 10th year after the tuberculosis (TB) epidemic in South Africa (SA) reached a historic peak of 848 incident TB cases per 100 000 population in 2008.[1,2] TB incidence has since decreased at an average of 2.0% annually to 781 per 100 000 in 2016.[1,2] The decline observed in the past decade has mainly been attributed to the expansion of HIV testing and antiretroviral therapy (ART).[1,2] Despite these and other public health efforts, TB remains a leading cause of death in SA,[1] and at the current rate of decline, SA will not reach the 2035 targets of the End TB Strategy.en_ZA
dc.description.urihttp://www.samj.org.za/index.php/samj/article/view/12370/0
dc.format.extent1 page
dc.language.isoen_ZAen_ZA
dc.publisherHealth & Medical Publishing Group
dc.subjectTuberculosisen_ZA
dc.subjectHIV infectionsen_ZA
dc.subjectAntiretroviral agentsen_ZA
dc.titleVariation in HIV prevalence and the population-level effects of antiretroviral therapy in reducing tuberculosis incidence in South Africaen_ZA
dc.typeArticleen_ZA
dc.description.versionPublisher's version
dc.rights.holderAuthors retain copyright


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

ITEM VIEW